These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 20547999)

  • 1. Sunitinib-induced pseudoprogression after whole-brain radiotherapy for metastatic renal cell carcinoma.
    Kelly PJ; Weiss SE; Sher DJ; Perez-Atayde AR; Dal Cin P; Choueiri TK
    J Clin Oncol; 2010 Sep; 28(25):e433-5. PubMed ID: 20547999
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of brain metastases from renal cell carcinoma with sunitinib and radiotherapy: our experience and review of the literature.
    Kusuda Y; Miyake H; Terakawa T; Furukawa J; Muramaki M; Fujisawa M
    Int J Urol; 2011 Apr; 18(4):326-9. PubMed ID: 25522450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifocal brain metastases in clear cell renal cell carcinoma with complete response to sunitinib.
    Zeng H; Li X; Yao J; Zhu Y; Liu J; Yang Y; Qiang W
    Urol Int; 2009; 83(4):482-5. PubMed ID: 19996660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sunitinib-induced acute psychosis: case report.
    Kunene V; Porfiri E
    Clin Genitourin Cancer; 2011 Sep; 9(1):70-2. PubMed ID: 21729680
    [No Abstract]   [Full Text] [Related]  

  • 5. High frequency of intracerebral hemorrhage in metastatic renal carcinoma patients with brain metastases treated with tyrosine kinase inhibitors targeting the vascular endothelial growth factor receptor.
    Pouessel D; Culine S
    Eur Urol; 2008 Feb; 53(2):376-81. PubMed ID: 17825982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial comment to "Treatment of brain metastases from renal cell carcinoma with sunitinib and radiotherapy: our experience and review of the literature".
    Hashimoto H
    Int J Urol; 2011 Apr; 18(4):329-30. PubMed ID: 21355893
    [No Abstract]   [Full Text] [Related]  

  • 7. Sunitinib in metastatic renal cell carcinoma patients with brain metastases.
    Gore ME; Hariharan S; Porta C; Bracarda S; Hawkins R; Bjarnason GA; Oudard S; Lee SH; Carteni G; Nieto A; Yuan J; Szczylik C
    Cancer; 2011 Feb; 117(3):501-9. PubMed ID: 20862748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance of sunitinib in dialyzed patients with metastatic renal cell carcinoma.
    Vickers MM; Heng DY; Hemmelgarn B; Eigl BJ
    Clin Genitourin Cancer; 2009 Oct; 7(3):E104-6. PubMed ID: 19815480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible myocardial dysfunction in a young woman with metastatic renal cell carcinoma treated with sunitinib.
    Szmit S; Nurzyński P; Szaluś N; Opolski G; Szczylik C
    Acta Oncol; 2009; 48(6):921-5. PubMed ID: 19191048
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversible posterior leukoencephalopathy syndrome induced by sunitinib.
    Martín G; Bellido L; Cruz JJ
    J Clin Oncol; 2007 Aug; 25(23):3559. PubMed ID: 17687168
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.
    Rini BI; Tamaskar I; Shaheen P; Salas R; Garcia J; Wood L; Reddy S; Dreicer R; Bukowski RM
    J Natl Cancer Inst; 2007 Jan; 99(1):81-3. PubMed ID: 17202116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute cardiac failure after sunitinib.
    Machiels JP; Bletard N; Pirenne P; Jacquet L; Bonbled F; Duck L
    Ann Oncol; 2008 Mar; 19(3):597-9. PubMed ID: 18272908
    [No Abstract]   [Full Text] [Related]  

  • 13. Sunitinib-induced macrocytosis in patients with metastatic renal cell carcinoma.
    Rini BI; Choueiri TK; Elson P; Khasawneh MK; Cotta C; Unnithan J; Wood L; Mekhail T; Garcia J; Dreicer R; Bukowski RM
    Cancer; 2008 Sep; 113(6):1309-14. PubMed ID: 18618496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain metastasis in renal cell cancer responding to sunitinib.
    Koutras AK; Krikelis D; Alexandrou N; Starakis I; Kalofonos HP
    Anticancer Res; 2007; 27(6C):4255-7. PubMed ID: 18214028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain magnetic resonance imaging changes after sorafenib and sunitinib chemotherapy in patients with advanced renal cell and breast carcinoma.
    Hill KL; Lipson AC; Sheehan JM
    J Neurosurg; 2009 Sep; 111(3):497-503. PubMed ID: 19199506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteonecrosis of the jaw after a single bisphosphonate infusion in a patient with metastatic renal cancer treated with sunitinib.
    Bozas G; Roy A; Ramasamy V; Maraveyas A
    Onkologie; 2010; 33(6):321-3. PubMed ID: 20523097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.
    Garfield DH; Hercbergs A; Davis PJ
    J Natl Cancer Inst; 2007 Jun; 99(12):975-6; author reply 976-7. PubMed ID: 17565154
    [No Abstract]   [Full Text] [Related]  

  • 18. Skin depigmentation induced by sunitinib treatment of renal cell carcinoma.
    Al Enazi MM; Kadry R; Mitwali H
    J Am Acad Dermatol; 2009 Nov; 61(5):905-6. PubMed ID: 19836653
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.
    Feldman DR; Martorella AJ; Robbins RJ; Motzer RJ
    J Natl Cancer Inst; 2007 Jun; 99(12):974-5; author reply 976-7. PubMed ID: 17565156
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to sorafenib after sunitinib-induced acute heart failure in a patient with metastatic renal cell carcinoma: case report and review of the literature.
    Wong MK; Jarkowski A
    Pharmacotherapy; 2009 Apr; 29(4):473-8. PubMed ID: 19323623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.